Octoparms® Vena Cava Filter Enters the Green Channel-Part 1

May 26, 2020, Octoparms® vena cava filter from Kossel Medtech entered the green channel of innovative medical devices of the National Medical Products Administration, balloon catheter becoming the sixth product entering the green channel in the cardiovascular field this year. As the first retrievable umbrella-type vena cava filter in China, Octoparms® has an independent invention […]

Clinical Applications Of Drug Eluting Balloon-Part 2

It does not require multi-polymers, does not induce advanced thrombosis, and may reduce the time of double antiplatelet therapy. Therefore, it is difficult for DES treatment, such as small blood vessels, anatomically curved blood vessels, diffuse long lesions, bifurcation lesions, and oral lesions,DEB is an alternative method. DEB still has some shortcomings: it cannot solve […]

Clinical Applications Of Drug Eluting Balloon-Part 1

Drug-eluting stents can inhibit the proliferation of smooth muscle cells in the vessel wall, balloon catheter and significantly reduce the restenosis rate after intervention compared with ordinary balloons and bare metal stents, but such stents also inhibit vascular endothelial repair, causing delayed or incomplete endothelialization, which is easy to induce Late thrombosis in the stent. […]

Current status of interventional treatment of coronary heart disease in China

In 1977, the first percutaneous transluminal coronary angioplasty (PTCA) opened the era of modern interventional cardiology, and interventional cardiology changed from diagnosis to treatment. After 30 years of development since the first case of coronary stent implantation in 1986, percutaneous coronary intervention (PCI) has become the most popular coronary intervention in the world balloon catheter. […]